regulated mainly by the combined action of enhancer I (EnI), enhancer II (Enll) and intervening regulatory sequences between EnI and EnlI (Su & Yee, 1992) . Liver-specific factors and ubiquitous factors regulate transcription from the pregenomic promoter through these two enhancers (LopezCabrera eta] ., 1991; Zhang et a] ., 1993).
The retinoblastoma gene (Rb) is a member of a class of cellular genes variously termed tumour suppressor genes, antioncogenes or recessive oncogenes (Weinberg, 1989) . The Rb protein forms complexes in vivo with the products of several viral oncogenes, such as SV40 large T antigen and adenovirus EIA (Weinberg, 1989) . It also forms complexes with E2F, a transcription factor that regulates viral and cellular gene expression, resulting in a marked reduction in E2F-dependent transcription (Hiebert et al., 1992) . Analysis of the sequences involved in the regulation of human c-fos, c-myc and TGF-fll gene expression by Rb has identified a common motif termed RCE (retinoblastoma control element) and Spl as one of its targets, either directly or indirectly (Kim et al., 1992b, c; Robbins et al., 1990; Udvadia et al., 1993 Udvadia et al., , 1995 .
In this report, we investigated whether the HBV pregenomic promoter is regulated by Rb in HepG2 cells. The results demonstrate that transient expression of human Rb stimulates the activity of the HBV pregenomic promoter through the Spl binding sites in human hepatoma (HepG2) cells. The Rb responsive element in HBV is similar to RCE, in having sequence homology and in its mechanism of regulation by Rb. Therefore, we also examined the function of the c-fos promoter RCE in HepG2 cells. Our results suggest that Rb can regulate the HBV pregenomic promoter through the Spl binding sites. The mechanism of regulation appears to be similar to that of c-fos in HepG2 cells.
The HBV pregenomic promoter overlaps with the core gene promoter and includes the EnI and EnII regions (Chen et al., 1995) . Thus, to determine whether Rb influences the pregenomic promoter, we used a plasmid, pCENCAT, containing EnI and EnII sequences between -1570 and + 58 of the HBV pregenomic promoter (Rho ei al., 1989) fused to the bacterial chloramphenicol acetyltransferase (CAT) reporter gene (Fig. la) figure. Cotransfection of 1.5 Hg of reporter plasmid (pCENCAT) with 3, 6 or 9 ~tg of Rb expression plasmid (phRb), respectively, into HepG2 cells was done by the calcium phosphate coprecipitation method. Forty-eight hours after transfection, cells were harvested and CAT activity was determined. Transfection efficiency was normalized by using a fl-galactosidase expression plasmid (pCH 110) as an internal control. (b) Mapping of the Rb-responsive element in the HBV pregenomic promoter. The deletion mutants (pCpBm, nt -4 2 0 ; pCpAp, nt -2 4 1 ; pCpSy, nt -178; pCpHc, nt -136; pCpDa, nt -9 6 ) were constructed by using the restriction enzyme sites. To analyse the inducibility by Rb, 1.5 #g of each plasmid DNA was cotransfected with 6 ~[g of the Rb expression plasmid (phRb) into HepG2 cells. phRb. Rb enhanced CAT expression approximately 3"5-fold (Fig. l a) , demonstrating that Rb could activate the HBV pregenomic promoter. A series of pregenomic promoter deletion constructs was cotransfected into HepG2 cells with phRb ( Fig. I b) . Plasmid pCpBm, containing the --420 to + 58 HBV region, was constructed by deletion of the EnI and X gene promoter regions from pCENCAT. The activity of pCpBm was increased approximately 3"5-fold by Rb, showing that HBV EnI is not involved in activation of the pregenomic promoter by Rb. As shown in Fig. 1 (b) , deletion of 5'-flanking sequences up to -96 (pCpDa) still allowed activation by Rb, suggesting that the region between -9 6 and + 58 is responsible for the Rb effect and that EnII is unlikely to participate. This region has basal pregenomic promoter activity and was already known to have two SpI binding sites as a cis-element (Rho et al., 1989; Zhang et al., 1993) . Therefore, we considered the possibility that the Rb responsive element was related to the Spl binding sites.
To test whether the effect of Rb on pregenomic promoter activity is mediated by the Spl binding sites located between -9 6 and + 58 in the pregenomic promoter, we synthesized oligonucleotides corresponding to this region [H_BV Rb responsive element, HRE) and oligonucleotides containing mutations in the Spl binding sites (HREM) (Fig. 2a) ) and an HRE probe. A 100-fold molar excess of unlabelled competitor oligonucleotide was used where indicated. Ten l~g of nuclear extract protein from HepG2 cells was incubated with 2 llg of poly(dl-dC) and unlabelled competitor; the labelled probe was then added and incubation was continued at room temperature for 15 min. The reaction mixtures were loaded onto a 6% nondenaturing polyacrylamide gel and electrophoresed. The gel was dried and exposed to X-ray film. The arrow indicates the HRE-Spl complex. (b) An HRE oligonucleotide probe was incubated in a DNA binding assay with purified Spl protein (Promega). Unlabelled competitors were as in (a).
constructed heterologous reporter plasmids by fusing two copies of the wild-type and mutant oligonucleotides to a thymidine kinase (tk) promoter-CAT vector, respectively. Rb marginally stimulated expression from the tk promoter alone, but addition of HRE activated CAT expression by Rb 2" 7-fold. In contrast, activation by the mutant construct was the same as that from the tk promoter by Rb (Fig. 2 b) . These results indicated that the two Spl binding sites in HRE were responsible for activation by Rb. We also tried to examine the responsiveness of the two Spl binding sites to Rb in a natural context. Using HREM as a PCR primer, we introduced mutations into the SpI binding sites of plasmids pCpHc and pCpDa, respectively. These mutant constructs were cotransfected with phRb plasmid into HepG2 cells. Mutations of both Spl binding sites decreased the basal expression level of the reporter plasmids and abolished activation by Rb (Fig.  2c) . These results suggested that Rb enhanced pregenomic promoter activity through the SpI binding sites. Since the effect of HRE was relatively low in HepG2 cells, we performed an additional experiment with Drosophila Schneider SL2 cells (an SpI-deficient cell line). Also, since the c-fos RCE is a representative Rb response element and its activation by Rb in SL2 cells has been reported previously (Udvadia et al., 1993) , we transfected the various plasmids described in Fig. 2 (b) and a construct containing wild-type c-fos RCE sequences linked to the tk promoter as a positive control and measured the activation. Cotransfection of the SpI plasmid and phRb resulted in an additional activation of the c-fos RCE and HRE constructs of 1"9-fold and 1"8-fold, respectively, under these conditions (Fig. 2d) . Thus, the effect of Rb seen in HepG2 cells (Fig. 2 b) was confirmed by the findings with SL2 cells (Fig. 2 d) .
To test whether Spi actually binds to this region, gel retardation assays were carried out with nuclear extracts from HepG2 cells and purified SpI protein (Promega). The oligonucleotide HRE was used as a probe and unlabelled HRE, HREM and Sp1 consensus sequences (Promega) were used as competitors. Two major retarded bands were detected with HepG2 nuclear extracts. These bands were reduced by competition with the wild-type oligonucleotide, but the upper band was not reduced by HREM and the lower band was reduced only partially. The upper band was completely abolished by the Spl consensus sequences oligonucleotide, but the other band was not (Fig. 3 a) . This result shows that HRE has a strong affinity for SpI protein whereas HREM does not. We next investigated whether purified Spl protein could bind to HRE and HREM. As shown in Fig. 3 (b) , a single HRE-Sp1
complex was formed and was competed out by an excess of unlabelled HRE or SpI consensus oligonudeotide, but not by HREM. Thus, the upper band formed with HepG2 nuclear extracts was a complex of HRE and Sp1.
Previously, it was reported that the HBV pregenomic promoter contained three Spl binding sites (Zhang et al., 1993) . One Sp1 binding site is located between -241 and -178, the other two between -96 and -66. The former site may also contribute to the activation by Rb. To test this possibility, we constructed a plasmid containing sequences from the -241 to -96 region linked to the tk promoter-CAT and cotransfected it with phRb into HepG2 cells. However, this region was little affected by Rb (data not shown). Thus, the two Spl binding sites located between -96 and + 58 are mainly responsible for activation by Rb.
We compared the sequence homology between RCE and the HBV Rb responsive element. A common motif of RCE is the 7 bp sequence 5' GCCACCC 3'. The HBV Rb responsive element contains the related sequence 5' TCCTCCC 3'. Mutational analysis of RCE has shown that positions 3, 5 and 7 are important for RCE activity (Kim et al., 1992c) . These bases are conserved in the HBV Spl binding site. Next, we compared c-fos RCE with HBV HRE. The c-fos RCE activated the tk promoter 2"3-fold in HepG2 cells and one of the two complexes detected in a gel retardation assay with c-fos RCE as a probe was a c-fos RCE-Spl complex (data not shown). These results were very similar to those obtained in assays with HBV HRE. We concluded that the HBV Rb responsive element was similar to the c-fos RCE in sequence and function. In HepG2 cells, the c-fos RCE and the HBV Rb responsive element activate transcription less than in other cell lines (Kim et al., 1992b, c; Robbins et aI., 1990; Udvadia et al., I993, 1995) . Since the gel shift pattern of HRE and c-fos RCE with HepG2 nuclear extract was different from that of other cell lines (Udvadia et al., 1993) , HepG2 cells may lack factors required along with SpI for full RCE activity.
HBV promoters have been reported to be regulated by several liver-enriched factors (Johnson eta] ., 1995). In addition, ubiquitously expressed transcription factors also affect the activity of HBV promoters (Reith et aI., 1994) . Presumably, the combined action of these factors and other as yet unidentified transcription factors may regulate the level of HBV transcripts during viral infection. Therefore, we suggest that Rb, as one of these transcription factors, participates in the control of the levels of pregenomic transcripts.
What could be the biological significance of these results? Generally, Rb is a protein that is active in the control of the cell cycle and its expression leads to growth arrest (DeCaprio et al., 1992) . In our experiments, HepG2 cells transfected with an Rbexpressing plasmid are similar to quiescent cells. Our results agree with the report by Sureau et al. (1986) stating that an increase in extrachromosomal HBV DNA was observed in confluent cells. In addition, expression of HBV is elevated in highly differentiated liver cells, but not in dedifferentiated hepatoma cells (Zhang et al., 1993) ; the activity of the Rb control element in the DBP (D-site binding protein) promoter was induced upon terminal differentiation (Leggett & Mueller, 1994) , and Rb plays an important role in terminally differentiated muscle cells (Gu ef aI., 1993) .
Thus, in conclusion, our findings suggest that HBV may have evolved a mechanism for optimal replication in the liver, an organ where there is normally very little cell turnover. With the hepatocytes in cell cycle arrest, active Rb would be expected to be present and to activate the HBV pregenomic promoter.
